OpenEvidence funding
OpenEvidence is an AI medical search and reference tool that answers clinical questions for doctors using peer-reviewed literature. Headquarters: Miami, United States. Website: openevidence.com.
Funding rounds
- OpenEvidence raises $250M Series D, . AI apps. Led by Thrive Capital, DST Global. OpenEvidence is an AI medical search and reference tool that answers clinical questions for doctors using peer-reviewed literature.
- OpenEvidence raises $200M Series C, . AI apps. Led by GV. OpenEvidence is an AI medical search and reference tool that answers clinical questions for doctors using peer-reviewed literature.
- OpenEvidence raises $210M Series B, . AI apps. Led by GV, Kleiner Perkins. OpenEvidence offers an AI medical search and clinical decision support tool for doctors.
Questions
How much has OpenEvidence raised?
OpenEvidence has raised $660M in the 3 rounds Funding tracks, most recently a Series D announced Jan 21, 2026.
What is OpenEvidence's valuation?
OpenEvidence was valued at $12B in its Series D round (Jan 21, 2026), as reported at the time.
Who invests in OpenEvidence?
Thrive Capital, DST Global, Sequoia, Nvidia, Kleiner Perkins, Blackstone, Bond, Craft Ventures, Mayo Clinic, GV, Sequoia Capital, Coatue Management, Craft, Coatue, Conviction.